Strs Ohio Denali Therapeutics Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Strs Ohio holds 17,400 shares of DNLI stock, worth $435,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,400

Previous 17,400 -0.0%

Holding current value

$435,870

Previous $404,000 25.25%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$14.96 - $23.22 $65,824 - $102,168	4,400 Added 33.85%	17,400 $404,000
Q1 2024 May 13, 2024	SELL	$15.83 - $23.35 $12,664 - $18,680	-800 Reduced 5.8%	13,000 $266,000
Q2 2023 Jul 31, 2023	SELL	$23.37 - $32.96 $189,297 - $266,976	-8,100 Reduced 36.99%	13,800 $407,000
Q1 2023 Aug 02, 2023	BUY	$21.91 - $32.67 $177,471 - $264,627	8,100 Added 58.7%	21,900 $504,000
Q1 2023 Apr 27, 2023	SELL	$21.91 - $32.67 $258,538 - $385,506	-11,800 Reduced 35.01%	21,900 $504,000
Q2 2022 Jul 25, 2022	BUY	$20.88 - $35.19 $58,464 - $98,532	2,800 Added 9.06%	33,700 $991,000
Q3 2021 Oct 22, 2021	SELL	$48.48 - $78.23 $14,543 - $23,469	-300 Reduced 0.96%	30,900 $1.56 Million
Q2 2021 Jul 26, 2021	BUY	$50.3 - $78.44 $231,380 - $360,824	4,600 Added 17.29%	31,200 $2.45 Million
Q1 2021 Apr 23, 2021	BUY	$53.8 - $81.53 $365,840 - $554,404	6,800 Added 34.34%	26,600 $1.52 Million
Q4 2020 Jan 25, 2021	BUY	$36.89 - $93.56 $291,431 - $739,124	7,900 Added 66.39%	19,800 $1.66 Million
Q2 2020 Jul 23, 2020	SELL	$16.01 - $28.82 $334,609 - $602,338	-20,900 Reduced 63.72%	11,900 $287,000
Q2 2019 Jul 25, 2019	BUY	$18.5 - $28.14 $606,800 - $922,992	32,800 New	32,800 $680,000
Q2 2018 Aug 06, 2018	SELL	$15.25 - $21.02 $70,150 - $96,692	-4,600 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$15.36 - $24.8 $70,656 - $114,080	4,600 New	4,600 $90,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.36B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account